← All trials
NCT05701527
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 28, 2023
- Primary completion
- Jun 11, 2026
- Completion date
- Jun 11, 2026
- First posted
- Jan 27, 2023
- Last posted
- Dec 19, 2023
- Enrollment
- 84
- Arms / groups
- 7 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.